Merck Changes Chickenpox Vaccine Insert to Include Shedding as a Side Effect

The U.S. FDA quietly approved a change in the package insert for Merck’s Varivax, or chickenpox vaccine, to include secondary transmission of the virus as a side effect of the vaccine. What this means is that Merck is admitting that recently vaccinated individuals can shed the virus (secondary transmission) to “susceptible,” i.e., unvaccinated, people. This can include “healthy as well as high-risk” individuals, the FDA said. Coincidentally, the varicella...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports